- In March 2022, Sandoz, a Novartis division, announced the acquisition of a UK-based medical and drug delivery device company, Coalesce Product Development Limited. Sandoz acquired Coalesce's expertise and assets as part of the arrangement, which will help the company expand its respiratory medication portfolio and improve patient access to high-quality, complex therapeutics
Frequently Asked Questions
The market is segmented based on Segmentation, By Product Type (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ophthalmic Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery), Application (Cancer, Diabetes, Respiratory Diseases, Cardiovascular Diseases, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2032
.
The Global Drug Delivery Market size was valued at USD 1.85 USD Billion in 2024.
The Global Drug Delivery Market is projected to grow at a CAGR of 8.5% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
